ArticleNeuropsychiatric disease and treatment2025
Age, Creatinine, and Ejection Fraction (ACEF) Score is Associated with the Presence of Depression and Anxiety Symptoms in PCI Patients.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A significant proportion of patients after percutaneous coronary intervention (PCI) have or develop comorbid depression and/or anxiety symptoms, which are associated with adverse events. The age, creatinine, and ejection fraction (ACEF) score is a good predictor for the prognostic assessment of certain cardiac diseases. But it has never been used to predict post-PCI depression and anxiety symptoms. Aim: To evaluate the possible association among ACEF score at admission, post-PCI anxiety, depression, comorbid anxiety and depression symptoms in hospital. Methods: After exclusion, a total of 222 patients undergoing emergency or selective PCI were enrolled and completed Hospital Anxiety and Depression Scale (HADS) to measure anxiety and depression symptoms before discharging. Patients were divided into four groups according to HADS score (anxiety, depression, comorbid anxiety and depression, neither anxiety nor depression). Logistic regression, linear regression and smoothed curve fitting (based on the penalized spline method) were used to analyze the relationship between ACEF score and post-PCI anxiety, depression symptoms. Receiver operating characteristic (ROC) curve analysis were performed to assess the value of ACEF score for predicting post-PCI anxiety, depression, comorbid anxiety and depression symptoms and to determine its critical values. Results: Of the sample, the number of patients who were diagnosed with post-PCI anxiety, depression and comorbid anxiety and depression symptoms were 16 (7.2%), 33 (14.9%) and 37 (16.7%), which increased with the ACEF score quartiles. In multivariate-adjusted logistic regression analysis, the odds ratios (ORs) of post-PCI anxiety, depression symptoms were 7.701 (1.613-36.766), 6.173 (1.608-28.028) for the lowest quartile of ACEF score compared with the highest quartile. Multivariate-adjusted linear regression and smoothed curve fitting analysis demonstrated that post-PCI anxiety and depression scores increased with higher ACEF scores, indicating a nonlinear positive correlation. The ROC curve showed that ACEF score was a good predictor for post-PCI anxiety, depression and comorbid anxiety and depression symptoms. Conclusion: Higher ACEF score is positively correlated with the prevalences of anxiety and depression symptoms after PCI in hospital, suggesting that ACEF score can be a valid predictor of depression and anxiety symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.